Pseudomyxoma Peritonei

Current Problems in Surgery

Volumn 45, Issue 8, 2008, Pages 527-575

  Smeenk, Robert M ^a   Bruin, Sjoerd C ^b   van Velthuysen, Marie Louise F ^b   Verwaal, Victor J ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYTOKERATIN 7; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; MELPHALAN; MITOMYCIN C; OXALIPLATIN; TRANSCRIPTION FACTOR CDX2;

ANASTOMOSIS LEAKAGE; APPENDECTOMY; ARTICLE; BONE MARROW TOXICITY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CYTOREDUCTIVE SURGERY; DISEASE COURSE; DISEASE FREE SURVIVAL; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PATIENT SELECTION; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; WOUND HEALING IMPAIRMENT;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 45849153427     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2008.04.003     Document Type: Article

References (157)

1. Limber G.K., King R.E., and Silverberg S.G. Pseudomyxoma peritonaei: a report of ten cases. Ann Surg 178 (1973) 587-593
2. Sugarbaker P.H., Ronnett B.M., Archer A., et al. Pseudomyxoma peritonei syndrome. Adv Surg 30 (1996) 233-280
3. Werth R. Klinische und anatomische untersuchungen zur lehre von den bauchgeschwuelsten und der laparotomie. Arch Gynaecol Obstet 24 (1884) 100-118
4. Fraenkel E. Ueber das sogennante pseudomyxoma peritonei. Munch Med Wochenschr 48 (1901) 965-971
5. Weaver C.H. Mucocele of the appendix with pseudomucinous degeneration. Am J Surg 36 (1937) 523
6. Cheng K.K. An experimental study of mucocele of the appendix and pseudomyxoma peritonei. J Pathol Bacteriol 61 (1949) 217-225 4 pl.
7. Sandenbergh H.A., and Woodruff J.D. Histogenesis of pseudomyxoma peritonei. Review of 9 cases. Obstet Gynecol 49 (1977) 339-345
8. Hughes J. Mucocele of the appendix with pseudomyxoma peritonei: a benign or malignant disease?. Ann Surg 165 (1967) 73-76
9. Smith G.E. Studies in the anatomy of the pelvis, with special reference to the fasciae and visceral supports: part I. J Anat Physiol 42 (1908) 198-218
10. Myer M.W. A malignant type of pseudomyxoma peritonei penetrating the spleen and colon. Ann Surg 45 (1907) 838-851
11. Byron Jr. R.L., Yonemoto R.H., King R.M., et al. The management of pseudomyxoma peritonei secondary to ruptured mucocele of the appendix. Surg Gynecol Obstet 122 (1966) 509-512
12. Muller G., Dirschmid K., Breitfellner G., et al. [Clinical aspects of pseudomyxoma peritonei]. Chirurg 55 (1984) 32-36
13. Friedland J.S., Allardice J.T., and Wyatt A.P. Pseudomyxoma peritonei. J R Soc Med 79 (1986) 480-482
14. Young R.H., Gilks C.B., and Scully R.E. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 15 (1991) 415-429
15. Seidman J.D., Elsayed A.M., Sobin L.H., et al. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 17 (1993) 22-34
16. Prayson R.A., Hart W.R., and Petras R.E. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. Am J Surg Pathol 18 (1994) 591-603
17. Ronnett B.M., Zahn C.M., Kurman R.J., et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei.". Am J Surg Pathol 19 (1995) 1390-1408
18. Sugarbaker P.H., Zhu B.W., Sese G.B., et al. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 36 (1993) 323-329
19. O'Connell J.T., Tomlinson J.S., Roberts A.A., et al. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 161 (2002) 551-564
20. Grodinsky M., and Rubnitz A.S. Mucocele of the appendix and pseudomyxoma peritonei: a clinical review and experimental study, with case report. Surg Gynecol Obstet 73 (1941) 345-354
21. Sugarbaker P.H. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 219 (1994) 109-111
22. Albelda S.M., and Buck C.A. Integrins and other cell adhesion molecules. FASEB J 4 (1990) 2868-2880
23. Lee B.Y., Kim H.S., Lee S.H., et al. Pseudomyxoma peritonei: extraperitoneal spread to the pleural cavity and lung. J Thorac Imaging 19 (2004) 123-126
24. Mortman K.D., Sugarbaker P.A., Shmookler B.M., et al. Pulmonary metastases in pseudomyxoma peritonei syndrome. Ann Thorac Surg 64 (1997) 1434-1436
25. Geisinger K.R., Levine E.A., Shen P., et al. Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review. Am J Clin Pathol 127 (2007) 135-143
26. Peek D.F., and Beets G.L. Pseudomyxoma peritonei in the pleural cavity: report of a case. Dis Colon Rectum 42 (1999) 113-115
27. Yoshida R., Yoshioka K., Yoshitaka H., et al. Pseudomyxoma peritonei of appendiceal cancer with metastasis to the stomach: report of a case. Surg Today 32 (2002) 547-550
28. Smeenk R.M., Verwaal V.J., Antonini N., et al. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol 14 (2007) 493-499
29. Mets T., Van Hove W., and Louis H. Pseudomyxoma peritonei. Report of a case with extraperitoneal metastasis and invasion of the spleen. Chest 72 (1977) 792-794
30. Bradley R.F., Stewart J.H., Russell G.B., et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 30 (2006) 551-559
31. Mukherjee A., Parvaiz A., Cecil T.D., et al. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 25 (2004) 411-414
32. Young R.H. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. Semin Diagn Pathol 21 (2004) 134-150
33. Sherer D.M., Abulafia O., and Eliakim R. Pseudomyxoma peritonei: a review of current literature. Gynecol Obstet Invest 51 (2001) 73-80
34. Smeenk R.M., Verwaal V.J., and Zoetmulder F.A. Pseudomyxoma peritonei. Cancer Treat Rev 33 (2007) 138-145
35. Ronnett B.M., Shmookler B.M., Diener-West M., et al. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16 (1997) 1-9
36. Smeenk R.M., Bex A., Verwaal V.J., et al. Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications. J Surg Oncol 93 (2006) 20-23
37. Chejfec G., Rieker W.J., Jablokow V.R., et al. Pseudomyxoma peritonei associated with colloid carcinoma of the pancreas. Gastroenterology 90 (1986) 202-205
38. de Bree E., Witkamp A., Van De Vijver M., et al. Unusual origins of pseudomyxoma peritonei. J Surg Oncol 75 (2000) 270-274
39. Szych C., Staebler A., Connolly D.C., et al. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 154 (1999) 1849-1855
40. Guerrieri C., Franlund B., Fristedt S., et al. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol 28 (1997) 1039-1045
41. Chuaqui R.F., Zhuang Z., Emmert-Buck M.R., et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol 27 (1996) 165-171
42. Cuatrecasas M., Matias-Guiu X., and Prat J. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol 20 (1996) 739-746
43. Smeenk R.M., van Velthuysen M.L., Verwaal V.J., et al. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34 (2008) 196-201
44. Ronnett B.M., Kurman R.J., Zahn C.M., et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 26 (1995) 509-524
45. Ronnett B.M., Shmookler B.M., Sugarbaker P.H., et al. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 2 (1997) 197-226
46. van E.S., Offerhaus G.J., Hart A.A., et al. Goblet cell carcinoid of the appendix: a specific type of carcinoma. Histopathology 51 (2007) 763-773
47. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92 (2001) 85-91
48. Cariker M., and Dockerty M. Mucinous cystadenomas and mucinous cystadenocarcinomas of the ovary; a clinical and pathological study of 355 cases. Cancer 7 (1954) 302-310
49. Smeenk R.M., Verwaal V.J., Antonini N., et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245 (2007) 104-109
50. Baratti D., Kusamura S., Nonaka D., et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 15 (2008) 526-534
51. Stewart J.H., Shen P., Russell G.B., et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13 (2006) 624-634
52. Deraco M., Kusamura S., Laterza B., et al. Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center. In Vivo 20 (2006) 773-776
53. Jacquemin G., and Laloux P. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases. Acta Chir Belg 105 (2005) 127-133
54. Sugarbaker P.H., and Jablonski K.A. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221 (1995) 124-132
55. Moran B.J., and Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12 (2003) 585-603
56. Kang H., O'Connell J.B., Maggard M.A., et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 48 (2005) 1161-1168
57. Kanemitsu Y., Kato T., Hirai T., et al. Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum 46 (2003) 160-167
58. Nozoe T., Anai H., Nasu S., et al. Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75 (2000) 103-107
59. Thomas R.M., and Sobin L.H. Gastrointestinal cancer. Cancer 75 (1995) 154-170
60. Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50 (2007) 113-130
61. Darnis E., Ronceray J., Grosieux P., et al. [Pseudomyxoma peritonei in females. 13 personal cases. Practical deductions from a review of 420 cases in the literature]. J Gynecol Obstet Biol Reprod (Paris) 16 (1987) 343-353
62. Mann Jr. W.J., Wagner J., Chumas J., et al. The management of pseudomyxoma peritonei. Cancer 66 (1990) 1636-1640
63. McCusker M.E., Cote T.R., Clegg L.X., et al. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 94 (2002) 3307-3312
64. Nielsen G.P., Isaksson H.J., Finnbogason H., et al. Adenocarcinoma of the vermiform appendix. A population study. APMIS 99 (1991) 653-656
65. Esquivel J., and Sugarbaker P.H. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 87 (2000) 1414-1418
66. Shinohara T., Misawa K., Sano H., et al. Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia. Int J Clin Oncol 11 (2006) 416-419
67. Esquivel J., and Sugarbaker P.H. Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair. Eur J Surg Oncol 27 (2001) 54-58
68. Edwards D.P., and Scott H.J. The use of laparoscopy in a case of appendiceal cystadenoma presenting as pseudomyxoma peritonei in an inguinal hernial sac. J R Coll Surg Edinb 43 (1998) 112-113
69. Rezkalla M.A., Peterson K.G., and Ryan J.J. Pseudomyxoma peritonei: a case of mucinous adenocarcinoma of the appendix presenting as inguinal hernia. S D Med 59 (2006) 54-55 57.
70. Skaane P., Isachsen M.M., and Hoiseth A. Computed tomography of mucin-producing adenocarcinoma of the appendix presenting as a bladder tumor. J Comput Assist Tomogr 9 (1985) 566-567
71. Deture F.A., Madorsky M.L., and Deardourff S.L. Adenocarcinoma of the appendix-a rare cause of right ureteral obstruction. J Urol 116 (1976) 514-515
72. Solkar M.H., Akhtar N.M., Khan Z., et al. Pseudomyxoma extraperitonei occurring 35 years after appendicectomy: a case report and review of literature. World J Surg Oncol 2 (2004) 19
73. Taii A., Sakagami J., Shinoda M., et al. Pseudomyxoma peritonei occurring after an uneventful 23 years interval from appendectomy. Intern Med 46 (2007) 1109-1112
74. Ruiz-Tovar J., Teruel D.G., Castineiras V.M., et al. Mucocele of the appendix. World J Surg 31 (2007) 542-548
75. Thompson M.A., Ashton R.W., and Pitot H.C. Mucinous appendiceal adenocarcinoma presenting 5 years after appendectomy. Ann Intern Med 140 (2004) W33
76. Vana J., Adamicova K., Johanes R., et al. [Appendiceal mucocele causing pseudomyxoma peritonei]. Zentralbl Chir 130 (2005) 177-180
77. Francica G., Lapiccirella G., Giardiello C., et al. Giant mucocele of the appendix: clinical and imaging findings in 3 cases. J Ultrasound Med 25 (2006) 643-648
78. Hanbidge A.E., Lynch D., and Wilson S.R. US of the peritoneum. Radiographics 23 (2003) 663-684
79. Tsai C.J. Ultrasound features of disseminated adenomucinosis (pseudomyxoma). Br J Radiol 71 (1998) 564-566
80. Bechtold R.E., Chen M.Y., Loggie B.W., et al. CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 26 (2001) 406-410
81. Kreel L., and Bydder G.M. Computed tomography of fluid collections within the abdomen. J Comput Tomogr 4 (1980) 105-115
82. Sulkin T.V., O'Neill H., Amin A.I., et al. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57 (2002) 608-613
83. de Bree E., Koops W., Kroger R., et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32 (2006) 65-71
84. Buy J.N., Malbec L., Ghossain M.A., et al. Magnetic resonance imaging of pseudomyxoma peritonei. Eur J Radiol 9 (1989) 115-118
85. Gollub M.J., DeCorato D., and Schwartz L.H. MR enteroclysis: evaluation of small-bowel obstruction in a patient with pseudomyxoma peritonei. AJR Am J Roentgenol 174 (2000) 688-690
86. Yang Q.M., Bando E., Kawamura T., et al. The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. Gan To Kagaku Ryoho 33 (2006) 1817-1821
87. Kairemo K.J., Jekunen A.P., Bondestam S., et al. Detection of pseudomyxoma peritonei by radioimmunohistochemistry and radioimmunoscintigraphy. Cancer Biother Radiopharm 11 (1996) 325-334
88. Lersch C., Frimberger E., Ott R., et al. Gray-scale sonographic findings in a patient with pseudomyxoma peritonei. J Clin Ultrasound 29 (2001) 186-191
89. Raj J., Urban L.M., ReMine S.G., et al. Laparoscopic management of pseudomyxoma peritonei secondary to adenocarcinoma of the appendix. J Laparoendosc Adv Surg Tech A 9 (1999) 299-303
90. Carmignani C.P., Hampton R., Sugarbaker C.E., et al. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol 87 (2004) 162-166
91. van Ruth S., Hart A.A., Bonfrer J.M., et al. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 9 (2002) 961-967
92. Baratti D., Kusamura S., Martinetti A., et al. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 14 (2007) 2300-2308
93. Alexander-Sefre F., Chandrakumaran K., Banerjee S., et al. Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence. Colorectal Dis 7 (2005) 382-386
94. Nonaka D., Kusamura S., Baratti D., et al. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology 49 (2006) 381-387
95. Semino-Mora C., Liu H., McAvoy T., et al. Pseudomyxoma peritonei: is disease progression related to microbial agents?. A study of bacteria, MUC2 and MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol 15 (2008) 1414-1423
96. Bibi R., Pranesh N., Saunders M.P., et al. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer 95 (2006) 1258-1264
97. Gonzalez-Moreno S., and Sugarbaker P.H. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 91 (2004) 304-311
98. Galani E., Marx G.M., Steer C.B., et al. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 13 (2003) 413-418
99. Little J.M., Halliday J.P., and Gleen D.C. Pseudomyxoma peritonei. Lancet 2 (1969) 846
100. Moran B.J., Mukherjee A., and Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg (2005)
101. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 219 (1994) 112-119
102. Smith J.W., Kemeny N., Caldwell C., et al. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 70 (1992) 396-401
103. Zoetmulder F.A., and Sugarbaker P.H. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 32A (1996) 1727-1733
104. Miner T.J., Shia J., Jaques D.P., et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241 (2005) 300-308
105. Sugarbaker P.H. Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma. Eur J Surg Suppl (1991) 75-82
106. Yan T.D., Black D., Savady R., et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14 (2007) 484-492
107. Verwaal V.J., van Tinteren H., Ruth S.V., et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85 (2004) 61-67
108. Sugarbaker P.H. Peritonectomy procedures. Surg Oncol Clin N Am 12 (2003) 703-727 xiii.
109. Sugarbaker P.H. Laser-mode electrosurgery. Cancer Treat Res 82 (1996) 375-385
110. Hermanek P., and Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol 10 (1994) 12-20
111. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
112. Sugarbaker P.H. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27 (2001) 239-243
113. Witkamp A.J., de Bree E., Van Goethem R., et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27 (2001) 365-374
114. Dedrick R.L., Myers C.E., Bungay P.M., et al. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62 (1978) 1-11
115. Jacquet P., and Sugarbaker P.H. Peritoneal-plasma barrier. Cancer Treat Res 82 (1996) 53-63
116. Sugarbaker P.H., Landy D., Jaffe G., et al. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 65 (1990) 1495-1501
117. Los G., Smals O.A., van Vugt M.J., et al. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 52 (1992) 1252-1258
118. Jacquet P., Vidal-Jove J., Zhu B., et al. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management. Acta Chir Belg 94 (1994) 191-197
119. Witkamp A.J., de Bree E., Kaag M.M., et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88 (2001) 458-463
120. van Ruth S., Mathot R.A., Sparidans R.W., et al. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokinet 43 (2004) 131-143
121. van Ruth S., Verwaal V.J., and Zoetmulder F.A. Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 12 (2003) 771-780
122. Butterworth S.A., Panton O.N., Klaassen D.J., et al. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 183 (2002) 529-532
123. Yan T.D., Links M., Xu Z.Y., et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg 93 (2006) 1270-1276
124. Elias D., Laurent S., Antoun S., et al. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]. Gastroenterol Clin Biol 27 (2003) 407-412
125. Murphy E.M., Sexton R., and Moran B.J. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 50 (2007) 37-42
126. van Leeuwen B.L., Graf W., Pahlman L., et al. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 15 (2008) 745-753
127. Smeenk R.M., Verwaal V.J., and Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur J Surg Oncol 32 (2006) 186-190
128. Deraco M., Baratti D., Inglese M.G., et al. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11 (2004) 393-398
129. Stephens A.D., Alderman R., Chang D., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6 (1999) 790-796
130. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 48 (2005) 1372-1379
131. Jacquet P., Jelinek J.S., Chang D., et al. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181 (1995) 530-538
132. Moran B.J. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf) 28 (2006) 375-378
133. Smeenk R.M., Verwaal V.J., and Zoetmulder F.A. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 94 (2007) 1408-1414
134. Yan T.D., Links M., Fransi S., et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 14 (2007) 2270-2280
135. Cavaliere F., Valle M., De R.B., et al. [Peritonectomy and chemohyperthermia in the treatment of peritoneal carcinomatosis: learning curve]. Suppl Tumori 4 (2005) S119-S121
136. Gonzalez-Moreno S. Peritoneal surface oncology: a progress report. Eur J Surg Oncol 32 (2006) 593-596
137. Haid M., Bowie L., Kim D., et al. Peritoneal washing therapy for pseudomyxoma peritonei. South Med J 74 (1981) 913-915
138. Green N., Gancedo H., Smith R., et al. Pseudomyxoma peritonei-nonoperative management and biochemical findings. A case report. Cancer 36 (1975) 1834-1837
139. Piver M.S., Lele S.B., and Patsner B. Pseudomyxoma peritonei: possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol 64 (1984) 95S-96S
140. Machado M.A., Rodrigues J.G., Laurino R.M., et al. [Conservative treatment of pseudomyxoma peritonei]. Rev Hosp Clin Fac Med Sao Paulo 48 (1993) 301-304
141. Sindelar W.F., DeLaney T.F., Tochner Z., et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 126 (1991) 318-324
142. Fernandez R.N., and Daly J.M. Pseudomyxoma peritonei. Arch Surg 115 (1980) 409-414
143. Mukherjee D., Nissen S.E., and Topol E.J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286 (2001) 954-959
144. Lang H., Jahne J., Flemming P., et al. Pseudomyxoma peritonei of appendiceal origin-a report of seven cases and a review of published reports. Eur J Surg 161 (1995) 355-360
145. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
146. Scuderi S., Costamagna D., Vaira M., et al. [Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy]. Tumori 89 (2003) 43-45
147. Guner Z., Schmidt U., Dahlke M.H., et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 20 (2005) 155-160
148. De Simone M., Vaira M., Caponi A., et al. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion. In Vivo 20 (2006) 725-727
149. Yan T.D., Bijelic L., and Sugarbaker P.H. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 14 (2007) 2289-2299
150. Sugarbaker P.H., Fernandez-Trigo V., and Shamsa F. Clinical determinants of treatment failure in patients with pseudomyxoma peritonei. Cancer Treat Res 81 (1996) 121-132
151. Miner T.J. The impact of therapy in the treatment of pseudomyxoma peritonei. Cancer Treat Res 134 (2007) 329-342
152. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol 7 (2006) 69-76
153. Esquivel J., and Sugarbaker P.H. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg 234 (2001) 198-205
154. Sugarbaker P.H. The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. Eur J Surg Oncol 32 (2006) 644-647
155. Harmon R.L., and Sugarbaker P.H. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2 (2005) 3
156. Sugarbaker P.H. Peritoneal surface oncology: review of a personal experience with colorectal and appendieal malignancy. Tech Coloproctol 9 (2005) 95-103
157. van Ruth S., Verwaal V.J., Hart A.A., van Slooten G.W., and Zoetmulder F.A. Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy. Anticancer Res 23 (2003) 1501-1508